Financials Kronox Lab Sciences Limited

Equities

KRONOX

INE0ATZ01017

Specialty Chemicals

Market Closed - NSE India S.E. 07:40:30 2024-07-05 EDT 5-day change 1st Jan Change
163.2 INR +6.10% Intraday chart for Kronox Lab Sciences Limited +6.60% 0.00%

Income Statement Evolution (Annual data)

Fiscal Period: März 2020 2021 2022 2023
Net sales 1 507.9 624.7 823.8 955.8
EBITDA 1 121.6 141.6 191.3 221.1
EBIT 1 112 131.8 180.8 207.7
Operating Margin 22.05% 21.09% 21.95% 21.73%
Earnings before Tax (EBT) 1 117.4 135 183.4 223.3
Net income 1 85.94 99.56 136.1 166.2
Net margin 16.92% 15.94% 16.52% 17.39%
EPS 2 2.122 2.550 3.486 4.310
Free Cash Flow - 77.05 23.3 79.45
FCF margin - 12.33% 2.83% 8.31%
FCF Conversion (EBITDA) - 54.4% 12.18% 35.94%
FCF Conversion (Net income) - 77.39% 17.12% 47.81%
Dividend per Share - - - -
Announcement Date 21-07-14 21-07-14 22-08-01 23-11-24
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: März 2020 2021 2022 2023
Net Debt 1 - - - -
Net Cash position 1 24.5 46.4 66.4 56.5
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - 77 23.3 79.5
ROE (net income / shareholders' equity) - 39.2% 40.2% 39.1%
ROA (Net income/ Total Assets) - 22.8% 23.8% 23.4%
Assets 1 - 436.3 572.3 709.2
Book Value Per Share 2 5.760 7.020 10.40 12.00
Cash Flow per Share 2 0.2000 0.2700 0.7200 0.9600
Capex 1 15.9 16.5 38 84.2
Capex / Sales 3.13% 2.64% 4.61% 8.8%
Announcement Date 21-07-14 21-07-14 22-08-01 23-11-24
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. KRONOX Stock
  4. Financials Kronox Lab Sciences Limited